kjamrvpsv@gmail.com
+919447535633
e-ISSN: 3107-4057
logo

Kottakkal Journal of Ayurvedic Medicine And Research

LoginTrack
Published

Elucidating The Therapeutic Potential Of Natural Herb Rubia Cordifolia (Manjishta) Through In Silico Approach Against The Drug Targets Of Psoriasis

Dr.Muhammed.M V
,
Dr.Benil.P B MD(Ayu), PhD
doi_icon
10.64541/KJAMR.Vol2.Iss3.000083

Published in July-September 2026 (Vol. 2, Issue 3, 2026)

Elucidating The Therapeutic Potential Of Natural Herb Rubia Cordifolia (Manjishta) Through In Silico Approach Against The Drug Targets Of Psoriasis - Issue cover

Keywords

BioinformaticsDrug discoveryIn-SilicoManjishtaMolecular dockingNetwork pharmacologyPsoriasisRubia cordifolia

Abstract

Background: Psoriasis is a chronic immune-mediated inflammatory skin disease with multiple phenotypically distinct subtypes.  Therapeutic options for psoriasis include topical therapy, phototherapy or systemic treatment.  Treatment targets include at least 75% or 90% improvement in PASI.  Despite its growing prevalence, current pharmacological options remain limited. Manjishta (Rubia cordifolia L), described in classical Ayurvedic literature under Varnya, Vishaghna and Jwarahara mahakashaya, possesses documented hepatoprotective, anti-inflammatory, anti-proliferative and antioxidant properties. This study aimed to evaluate the potential molecular mechanisms of Manjishta phytoconstituents against psoriasis associated targets using in-silico approaches. Methods: Phytoconstituents of Rubia cordifolia L were retrieved from the IMPPAT and PubChem databases. ADME properties and drug-likeness were assessed using SwissADME, and bioavailability was visualized using the Boiled Egg model. Protein–protein interaction (PPI) networks were constructed via STRING. Molecular docking was performed using AutoDock Vina against key psoriasis related proteins. Docking interactions were analyzed in Discovery Studio Visualizer. Results: Phytoconstituents such as lucidin ethyl ether, xanthopurpurin, 1-hydroxy-2-methoxyanthraquinone, rubiadin, 1-hydroxy-2-methylanthraquinone and 2-(methoxymethyl)-1,3-dihydroxyanthraquinone demonstrated strong binding affinities (−7.0 to −8.4 kcal mol-1) toward estrogen receptor beta, neutrophil elastase, induced myeloid leukemia cell differentiation protein Mcl-1 and M-phase inducer phosphatase . ADME analysis indicated favorable oral bioavailability and compliance with Lipinski’s rule of five. The PPI network highlighted ESR1, BCL2, CASP3, DNMT1, TERT, PTPRC, DNMT3A, ESR2, MCL1 and ELANE as central nodes associated with psoriasis pathology, suggesting multi-target modulatory potential. Conclusion: This in-silico analysis predicts potential interactions of Rubia cordifolia phytoconstituents with key apoptotic, anti-inflammatory, anti-proliferative and antioxidant pathways implicated in psoriasis. These findings warrant further experimental research to validate their biological relevance.

References

  1. [1]Mishra BP. Bhavprakash Nighantu Edited by Padmashree Pro. Krushnachandra Chunekar. Reprint Edition. Chaukhambha Bharati Academy. 2022.
  2. [2]Charak Samhita Sutrasthana, Shadavirechanashatasriteeya Adhyaya, 4/8,16,39. Available from: http://niimh.nic.in/ebooks/echarak. [Last accessed on 2026 Mar 09].
  3. [3]Wen M, Chen Q, Chen W, Yang J, Zhou X, Zhang C, Wu A, Lai J, Chen J, Mei Q, Yang S. A comprehensive review of Rubia cordifolia L.: Traditional uses, phytochemistry, pharmacological activities, and clinical applications. Frontiers in pharmacology. 2022 Sep 9;13:965390.
  4. [4]Humbare RB, Sarkar J, Kulkarni AA, Juwale MG, Deshmukh SH, Amalnerkar D, Chaskar M, Albertini MC, Rocchi MB, Kamble SC, Ramakrishna S. Phytochemical characterization, antioxidant and anti-proliferative properties of Rubia cordifolia L. extracts prepared with improved extraction conditions. Antioxidants. 2022 May 20;11(5):1006.
  5. [5]Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clinical Medicine. 2021 May 1;21(3):170-3.
  6. [6]Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. Jama. 2020 May 19;323(19):1945-60.
  7. [7]Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. Jama. 2020 May 19;323(19):1945-60.
  8. [8]Lin ZX, Jiao BW, Che CT, Zuo Z, Mok CF, Zhao M, Ho WK, Tse WP, Lam KY, Fan RQ, Yang ZJ. Ethyl acetate fraction of the root of Rubia cordifolia L. inhibits keratinocyte proliferation in vitro and promotes keratinocyte differentiation in vivo: potential application for psoriasis treatment. Phytotherapy research. 2010 Jul;24(7):1056-64.
  9. [9]ref-Marilyn Safran, Naomi Rosen, Michal Twik, Ruth BarShir, Tsippi Iny Stein, Dvir Dahary, Simon Fishilevich, Doron Lancet. GeneCards Version 5: The comprehensive knowledgebase for human genes. Database. 2021;2021:baab111.
  10. [10]Oliveros JC. Venny: An interactive tool for comparing lists with Venn diagrams. BioinfoGP, CNB-CSIC. 2007–2015. Available at: http://bioinfogp.cnb.csic.es/tools/venny/.
  11. [11]Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, Jensen LJ, Mering CV. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613. doi: 10.1093/nar/gky1131.
  12. [12]Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003 Nov;13(11):2498-504. doi: 10.1101/gr.1239303.
  13. [13]Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. CytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.
  14. [14]Morris GM, Lim-Wilby M. Molecular docking. Methods Mol Biol. 2008;443:365–382.) (Ferreira LG, dos Santos RN, Oliva G, Andricopulo AD. Molecular docking and structure-based drug design strategies. Molecules. 2015;20(7):13384–13421.
  15. [15]O. Trott, A. J. Olson. AutoDock Vina: improving the speed and accuracy of with a new scoring function, efficient optimization and multithreading. Journal of Computational Chemistry 31 (2010) p. 455-461 DOI 10.1002/jcc.21334) (Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ. Computational protein–ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc. 2016;11(5):905–919.
  16. [16]Widden, H., Placzek, W.J. The multiple mechanisms of MCL1 in the regulation of cell fate. Commun Biol 4, 1029 (2021). https://doi.org/10.1038/s42003-021-02564-6.
  17. [17]Macleod, T., Doble, R., McGonagle, D., Wasson, C., Alase, A., Stacey, M., & Wittmann, M. Neutrophil Elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 Receptor antagonist. Scientific Reports. 2016; 6. https://doi.org/10.1038/srep24880.
  18. [18]Zeng, W., Song, Y., Wang, R., He, R., & Wang, T. Neutrophil elastase: From mechanisms to therapeutic potential. Journal of Pharmaceutical Analysis. 2023; 13. https://doi.org/10.1016/j.jpha.2022.12.003.
  19. [19]Başar Kılıç Ş, Taheri S, Mehmetbeyoğlu Duman E, Öksüm Solak E, Yılmaz Şükranlı Z, Rassoulzadegan M, Borlu M. Psoriatic skin transcript phenotype: androgen/estrogen and cortisone/cortisol imbalance with increasing DNA damage response. Mol Biol Rep. 2024 Aug 24;51(1):933. doi: 10.1007/s11033-024-09782-1. PMID: 39180588.
  20. [20]Fu, Z., He, Y., Gao, L., Tong, X., Zhou, L., & Zeng, J. STAT2/Caspase3 in the diagnosis and treatment of psoriasis. European Journal of Clinical Investigation. 2023; 53. https://doi.org/10.1111/eci.13959.
  21. [21]Sur, S., & Agrawal, D. Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies. Molecular and Cellular Biochemistry. 2016; 416. https://doi.org/10.1007/s11010-016-2693-2.
  22. [22]Liu, K., Zheng, M., Lu, R., Du, J., Zhao, Q., Li, Z., Li, Y., & Zhang, S. The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review. Cancer Cell International. 2020; 20. https://doi.org/10.1186/s12935-020-01304-w.
  23. [23]Gelmi, M., Houtzagers, L., Strub, T., Krossa, I., & Jager, M. MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance. International Journal of Molecular Sciences. 2022; 23. https://doi.org/10.3390/ijms23116001.

Authors (2)

Dr.Muhammed.M V

PG Scholar, Department of Agad...

View all publications →

Dr.Benil.P B MD(Ayu), PhD

Professor and HOD, Department ...

View all publications →

Download Article

PDF

Best for printing and citation

File size: 0.7 MB
Format: PDF

Summarise this paper with AI:

GoogleGooglePerplexityPerplexityGrokGrokChatGPTChatGPTClaudeClaude

Article Information

Published in:

July-September 2026 (Vol. 2, Issue 3, 2026)

KJAMR320001

KJAMR-01-000083

1-18

2026-06-30

JATS XML

Article Impact

Views:80
Downloads:29
scite_
PlumX Metrics Badge

How to Cite

V & Dr.Benil.P B MD(Ayu), PhD (2026). Elucidating The Therapeutic Potential Of Natural Herb Rubia Cordifolia (Manjishta) Through In Silico Approach Against The Drug Targets Of Psoriasis. Kottakkal Journal of Ayurvedic Medicine And Research, 2(3), 1-18. DOI:https://doi.org/10.64541/KJAMR.Vol2.Iss3.000083

Article Actions